Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Ciprofloxacin 250mg/5ml oral suspension |
BNF code | 0501120L0AABGBG |
Virtual Therapeutic Moiety | Ciprofloxacin |
Date identifier became valid | 9 May 2023 |
Previous product identifier | 324602005 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 5.000 |
Unit dose form units | ml |
Unit dose unit of measure | spoonful |
Virtual Product Ingredient | |
---|---|
Ingredient | Ciprofloxacin |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 50.000 |
Strength value numerator unit | mg |
Strength value denominator | 1.000 |
Strength value denominator unit | ml |
Ontology Drug Form & Route | |
Form & Route | suspension.oral |
Dose Form | |
Formulation | Oral suspension |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Ciprofloxacin 250mg/5ml oral suspension (Drugsrus Ltd) | |
Ciproxin 250mg/5ml oral suspension (Bayer Plc) | |
Ciproxin 250mg/5ml oral suspension (Lexon (UK) Ltd) | |
Ciproxin 250mg/5ml oral suspension (Necessity Supplies Ltd) | |
Virtual Medicinal Product Packs | |
Ciprofloxacin 250mg/5ml oral suspension 100 ml | |
Ciprofloxacin 250mg/5ml oral suspension 30 ml |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.